Giornale Italiano Di Cardiologia·Oct 27From guidelines: cardiovascular risk stratification and therapeutic targetsReviewInterventionsPaper
Giornale Italiano Di Cardiologia·Oct 27Role of statin/ezetimibe fixed-dose combination in lipid risk management in the cardiovascular disease continuumReviewStatin + ezetimibePaper
ESC Congress 2026 Abstract·Oct 26Apolipoprotein b discordance at very low low-density lipoprotein cholesterol thresholds: a patient-level analysisCross-sectional study of 204 peopleInterventionsPaper
ESC Congress 2026 Abstract·Oct 26Intensive lipid lowering therapy improves microvascular function assessed by retinal vessel analysis in patients after ST-elevation myocardial infarctionCohort study of 12 peopleST-elevation myocardial infarctionPaper
ESC Congress 2026 Abstract·Oct 26Association of LDL-C/ApoB ratio with pathogenic variants in familial hypercholesterolemiaCohort study of 113 peopleFamilial hypercholesterolemiaPaper
ESC Congress 2026 Abstract·Oct 26Achievement of LDL-C targets in clinical practice in Spain: a comparison between Observatory II and Observatory ICross-sectional study of 4,010 peoplePopulationsPaper
ESC Congress 2026 Abstract·Oct 26FH genotype stratifies LDL-C–lowering response and improves diagnostic discrimination in severe hypercholesterolemiaCross-sectional study of 399 peopleHeterozygous familial hypercholesterolemiaPaper
ESC Congress 2026 Abstract·Oct 26Upfront combination lipid-lowering therapy in statin-naive acute coronary syndrome patients with high admission LDL-C: real-world support for the 2025 ESC dyslipidaemias guidelinesCohort study of 923 peopleAcute coronary syndromePaper
ESC Congress 2026 Abstract·Oct 26Comparative effectiveness of lipid-lowering regimens for achieving ESC LDL-cholesterol targets in acute coronary syndrome: a real-world cohort analysisCohort study of 298 peopleAcute coronary syndromePaper
ESC Congress 2026 Abstract·Oct 26Association of cancer incidence and cancer mortality with statins, ezetimibe, and statin–ezetimibe therapy: a pairwise and bayesian network meta-analysis of randomized controlled trialsMeta-analysis of randomized trialsStatinsPaper
ESC Congress 2026 Abstract·Oct 26Upfront combination lipid-lowering therapy in acute coronary syndrome: a bayesian network meta-analysis of low-density lipoprotein cholesterol reduction and major adverse cardiovascular eventsMeta-analysisAcute coronary syndromePaper
Daru·Oct 25Association between perioperative statin-ezetimibe therapy and reoperation following arthroscopic rotator cuff repair: A TriNetX database studyCohort study of 1,114 peopleStatin + ezetimibePaper
Frontiers in Pharmacology·Oct 20Liver enzyme elevations during statin-ezetimibe therapy in ABCG2 c.421C>A variant carriers: a case series and narrative reviewCase series of 11 peopleStatin + ezetimibePaper
Journal of Clinical Lipidology·Sep 9Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysisMeta-analysisStatin + ezetimibePaper
Endocrinology and Metabolism·Sep 2Ezetimibe Treatment Is Associated with Lower Risk of Incident Cancer: A Nationwide Population-Based Cohort StudyCohort study of 669,036 peopleStatin + ezetimibePaper
Nutrition, Metabolism, and Cardiovascular Diseases·Aug 11Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updatesCohort study of 1,379 peoplePopulationsPaper
Cureus·Jul 21Evaluating the Safety and Efficacy of Moderate-Intensity Statin Combined With Ezetimibe in Elderly Patients With Atherosclerotic Cardiovascular DiseaseCohort study of 221 peopleStatin + ezetimibePaper
ADA Scientific Sessions 2025 Abstract·Jun 13Combination Lipid-Lowering Therapy and the Risks of Various Types of Cancers in Patients with Type 2 DiabetesCohort study of 299,472 peopleCancerPaper
Journal of the American College of Cardiology·Apr 6Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With AtherosclerosisRandomized trial in 3,780 peopleStatin + ezetimibePaper
Open Heart·Apr 24Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatmentCohort study of 462 peopleIschemic strokePaper
Aging and Disease·Dec 10The safety and efficacy of Ezetimibe Plus Statins on ASVD and Related DiseasesReviewStatin + ezetimibePaper